PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Clinical trials reveal promising alternatives to high-toxicity tuberculosis drug

Research shows two novel antibiotics could spare patients from severe side effects

2025-07-08
(Press-News.org) The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile compared to linezolid, with potential to replace this current cornerstone in the treatment of drug-resistant TB. The findings were published on 7 July in two peer-reviewed articles in The Lancet Infectious Diseases, one of the world’s leading journals in the field of infectious disease medicine. Research partners in Europe included Radboud university medical center from the Netherlands and the German Center for Infection Research (DZIF), Munich, the Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, the Center for International Health at LMU University Hospital and Helmholtz Munich.

The Challenge with Linezolid

In 2022, the World Health Organisation introduced lineozid as part of the BPaLM regimen, also comprising bedaquiline, pretomanid, and moxifloxacin, as the standard recommended 6-month treatment for patients with multidrug-resistant TB—reducing the duration from the previous standard 18 months. However, linezolid is problematic for patients as it shows significant toxicity. This prolonged exposure to linezolid, much longer than the originally intended use for bacterial skin infections, frequently leads to serious adverse events like anaemia or optical neuropathy, which are distressing for patients, may not resolve fully, and can require discontinuation of therapy, limiting treatment success.

“Despite its effectiveness, linezolid is simply too toxic for many patients. We urgently need safer alternatives in this antibiotic class,” says PD Dr Norbert Heinrich.

Both sutezolid and delpazolid are members of the oxazolidinone class, like linezolid, but are less toxic for patients. In two innovative Phase 2b clinical trials – SUDOCU (PanACEA Sutezolid Dose-finding and Combination Evaluation) and DECODE (PanACEA DElpazolid Dose-finding and COmbination DEvelopment) – both drugs were tested in combination with bedaquiline, delamanid, and moxifloxacin, making them the first trials to use these specific four-drug combinations. The studies, conducted in South Africa and Tanzania, showed that in patients with drug-sensitive pulmonary TB, both drugs are safer and more tolerable for patients than linezolid would be.

Key findings show better patient outcomes

Sutezolid was shown to be effective with strong antibacterial activity and was well tolerated across all tested doses, with no cases of nerve damage or blood toxicity—a critical advantage over linezolid. These results suggest sutezolid could be a safer alternative for future TB treatment regimens, particularly in long-term use, although no final dose recommendation can be made yet.  

Delpazolid enhanced the effectiveness of the combination regimen with bedaquiline, delamanid, and moxifloxacin. A once-daily dose of 1200 mg achieved the desired drug levels for maximum efficacy and was well tolerated over 16 weeks. Importantly, no cases of nerve damage or blood-related side effects were observed at this dose. These results position delpazolid as a promising alternative to linezolid for future TB treatment regimens—pending confirmation in larger studies.

“These findings suggest that both drugs may offer safer treatment options for TB patients, particularly those requiring longer courses of therapy,” – noted Dr Tina Minja, National PI for the DECODE study at NIMR-Mbeya Medical Research Centre in Tanzania.

A Collaborative Global Effort

The studies were conducted as part of the PanACEA (Pan-African Consortium for the Evaluation of Anti-Tuberculosis Antibiotics) network, which includes clinical and academic partners across Africa and Europe. Both the SUDOCU and DECODE trials were innovative Phase 2b, open-label, randomized clinical studies that systematically compared different dosing levels to evaluate antibacterial activity, drug exposure, and safety profiles of sutezolid and delpazolid.

Looking Ahead

The publication in The Lancet Infectious Diseases underscores the scientific relevance of these results and their potential to shape future TB treatment strategies. “Seeing fewer side effects with sutezolid and delpazolid is a significant step forward—it brings us closer to TB therapies that are both effective and easier for patients to tolerate”, commented Dr Ivan Norena, medical team lead at the Institute of Infectious Diseases and Tropical Medicine at LMU University Hospital Munich.

Further research is now planned to evaluate sutezolid and delpazolid in larger cohorts and in fully optimized treatment combinations. If the promising results are confirmed, these drugs could play a critical role in the next generation of TB therapies, helping to reduce treatment-related side effects while maintaining efficacy.

Elin Svensson, senior researcher from Radboud university medical center led the data analysis in both studies. She says: ‘These findings are encouraging and show there is hope for better drugs for drug-resistant TB. Without the collaboration within PanACEA, this would not have been possible in such a short time. It highlights the importance of tackling TB as a global community.’

END


ELSE PRESS RELEASES FROM THIS DATE:

Artificial solar eclipses in space could shed light on Sun

2025-07-08
Recreating artificial solar eclipses in space could help astronomers decipher the inner workings of our Sun much quicker than if they had to wait for the celestial show on Earth. The plan, part of a UK-led space mission to be unveiled at the Royal Astronomical Society’s National Astronomy Meeting 2025 in Durham, would involve the use of a mini-satellite and the Moon's shadow to achieve the closest-ever views of the Sun's atmosphere. The Moon-Enabled Sun Occultation Mission (MESOM) proposes a novel way to study the inner solar corona – the innermost layer of the Sun's atmosphere, which ...

Probing the cosmic Dark Ages from the far side of the Moon

2025-07-08
Royal Astronomical Society press release RAS PR 25/26 (NAM 6) 8 July 2025 Embargoed until Wednesday 9 July 2025 at 00:01 BST Astronomers want to unlock the secrets of the 'Cosmic Dawn' by sending a miniature spacecraft to listen out for an "ancient whisper" on the far side of the Moon. The proposed mission will study the very early universe, right after the Big Bang, when it was still quite dark and empty before the first stars and galaxies appeared. But to probe the cosmic 'Dark ...

UK hopes to bolster space weather forecasts with Europe's first solar storm monitor

2025-07-08
Royal Astronomical Society press release RAS PR 25/27 (NAM 7) 8 July 2025 Embargoed until Wednesday 9 July 2025 at 00:01 BST A new UK-led satellite mission concept aims to strengthen the country's position in space weather observation and forecasting by deploying a suite of homegrown scientific instruments on a low-cost spacecraft in low-Earth orbit. The proposal is being presented today (Wednesday) at the Royal Astronomical Society's National Astronomy Meeting 2025 in Durham. UK-ODESSI ...

Can one video change a teen's mindset? New study says yes - but there’s a catch

2025-07-08
A mental health hack designed to promote mental well-being could shift how teenagers view themselves – according to new research from the University of East Anglia. A new study published today shows how watching a one-off ten-minute video can positively change young people’s beliefs about their personality traits. But the intervention appeared to have little immediate effect on symptoms of anxiety or depression. The findings add to a growing body of evidence that mental health support delivered online can play a valuable role - but may work best as part of a broader toolkit of services. The team say that more ...

How lakes connect to groundwater critical for resilience to climate change, research finds

2025-07-08
Understanding whether lakes are fed predominantly by groundwater or rainwater is critical to managing our water resources in the face of droughts and shortages, new research has found. The study drew on data from 350 lakes across 18 European countries, collected between 2022 and 2024, to provide a comprehensive picture of how the continent’s lakes are coping with climate change. The research is presented today [Wednesday 9 July, 2025] at the Goldschmidt Conference in Prague. The researchers, from the Czech Academy of Sciences, analysed the proportions of stable hydrogen and oxygen isotopes (18O and 2H) in the lakes’ ...

Youngest basaltic lunar meteorite fills nearly one billion-year gap in Moon’s volcanic history

2025-07-08
A 2.35-billion-year-old meteorite with a unique chemical signature, found in Africa in 2023, plugs a major gap in our understanding of the Moon’s volcanic history.   Presented today [Wednesday 9 July] at the Goldschmidt Conference in Prague, findings from analyses of the Northwest Africa 16286 meteorite offer fresh insights into how the Moon’s interior evolved, highlighting the long-lived nature of its volcanic activity. Analyses by researchers from the University of Manchester, UK, lend weight to a theory that the Moon retained internal heat-generating processes that powered ...

Cal Poly Chemistry professor among three U.S. faculty to be honored for contributions to chemistry instruction

2025-07-08
A Cal Poly chemistry professor is among three U.S. university faculty to be awarded the national Jack Flack Norris Award for outstanding teaching in chemistry by the American Chemical Society. Dr. Phil Costanzo is being recognized for his work with the Macromolecular Alliance for Community Resources & Outreach (MACRO), a joint service committee of two American Chemical Society divisions: Polymer Chemistry (POLY) and Polymeric Materials: Science & Engineering (PMSE).  The award celebrates MACRO’s outstanding achievements in chemistry education and its extensive, ...

Stoichiometric crystal shows promise in quantum memory

2025-07-08
For over two decades, physicists have been working toward implementing quantum light storage—also known as quantum memory—in various matter systems. These techniques allow for the controlled and reversible mapping of light particles called photons onto long-lived states of matter. But storing light for long periods without compromising its retrieval efficiency is a difficult task. In recent years, rare earth atoms in solid materials at cryogenic temperatures have shown to be promising for quantum memory. ...

Study sheds light on why some prostate tumors are resistant to treatment

2025-07-08
ANN ARBOR, Michigan — A new study from University of Michigan Rogel Cancer Center researchers identifies a cellular signature that explains why about one-third of prostate cancers respond especially poorly to treatment.   Treatments such as enzalutamide, which is an androgen receptor pathway inhibitor (ARPI), are standard of care for advanced prostate cancer. While many patients have long-term good response to the drugs, some will derive no benefit whatsoever. These “extreme non-responder” patients die much more quickly ...

Tree pollen reveals 150,000 years of monsoon history—and a warning for Australia’s northern rainfall

2025-07-08
Northern Australia's annual monsoon season brings relief to drought-stricken lands and revitalises crops and livestock for farmers. But a study of 150,000 years of climate records shows that the monsoon is likely to intensify — triggering a higher risk of flooding while worsening the impact of droughts in East Asia. Led by Professor Michael Bird, researchers at James Cook University and Flinders University have assessed sediments at Girraween Lagoon near Darwin, revealing a continuous record of monsoon rainfall patterns dating back beyond the last interglacial period. This ...

LAST 30 PRESS RELEASES:

Duration of heat waves accelerating faster than global warming

New mathematical insights into Lagrangian turbulence

Clinical trials reveal promising alternatives to high-toxicity tuberculosis drug

Artificial solar eclipses in space could shed light on Sun

Probing the cosmic Dark Ages from the far side of the Moon

UK hopes to bolster space weather forecasts with Europe's first solar storm monitor

Can one video change a teen's mindset? New study says yes - but there’s a catch

How lakes connect to groundwater critical for resilience to climate change, research finds

Youngest basaltic lunar meteorite fills nearly one billion-year gap in Moon’s volcanic history

Cal Poly Chemistry professor among three U.S. faculty to be honored for contributions to chemistry instruction

Stoichiometric crystal shows promise in quantum memory

Study sheds light on why some prostate tumors are resistant to treatment

Tree pollen reveals 150,000 years of monsoon history—and a warning for Australia’s northern rainfall

Best skin care ingredients revealed in thorough, national review

MicroRNA is awarded an Impact Factor Ranking for 2024

From COVID to cancer, new at-home test spots disease with startling accuracy

Now accepting submissions: Special Collection on Cognitive Aging

Young adult literature is not as young as it used to be

Can ChatGPT actually “see” red? New results of Google-funded study are nuanced

Turning quantum bottlenecks into breakthroughs

Cancer-fighting herpes virus shown to be an effective treatment for some advanced melanoma

Eliminating invasive rats may restore the flow of nutrients across food chain networks in Seychelles

World’s first: Lithuanian scientists’ discovery may transform OLED technology and explosives detection

Rice researchers develop superstrong, eco-friendly materials from bacteria

Itani studying translation potential of secure & efficient software updates in industrial internet of things architectures

Elucidating the source process of the 2021 south sandwich islands tsunami earthquake

Zhu studying use of big data in verification of route choice models

Common autoimmune drug may help reverse immunotherapy-induced diabetes, UCLA study finds

Quantum battery device lasts much longer than previous demonstrations

Gamma knife stereotactic radiosurgery for brain metastases from ovarian cancer

[Press-News.org] Clinical trials reveal promising alternatives to high-toxicity tuberculosis drug
Research shows two novel antibiotics could spare patients from severe side effects